Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Nobina obtains investment grade credit rating from Fitch (BBB-, stable outlook)

Nobina AB, the leading bus operator in the Nordic region, has received an investment grade credit rating of BBB- with a stable outlook from the international credit rating agency Fitch Ratings.Fitch Ratings states that Nobina’s credit rating reflects the company’s “leading position in the Nordic public transport sector by bus with favorable market dynamics, operations under long-term contracts with limited market risk, track record of contract migration and fleet management and stable and predictable cash flow generation.”   “The BBB- rating reflects Nobina’s financial situation and

Saab Receives RBS 70 NG Order for the Czech Republic’s Armed Forces

Saab has signed a contract to supply The Armed Forces of the Czech Republic with RBS 70 NG, the latest generation of the RBS 70 man-portable air defence system. The order is valued at 365 MSEK and deliveries will take place in 2020 and 2021.In addition to the system itself, the order also includes integration with Czech Air Defence, test equipment and training. The Armed Forces of the Czech Republic is already a user of RBS 70, the preceding version of the system. “We are happy to provide the Armed Forces of the Czech Republic with Saab's newest short range air defence system; RBS 70 NG.

IRLAB provides update on drug candidate IRL790’s clinical program

IRLAB today provided an update on the clinical program for the drug candidate IRL790 in development for the treatment of dyskinesia and psychosis in Parkinson's disease, with the following highlights: · Based on advice in a recent FDA pre-IND meeting, the company received confirmation that performed and planned pre-clinical studies and CMC-program in the development of IRL790 are sufficient to apply for an IND. · Currently, IRL790 is undergoing a clinical Phase IIa trial in Parkinson’s disease patients with dyskinesias. The study’s independent Data Safety Monitoring Board (DSMB) has

Gaming Innovation Group applies for Spanish licence as part of expansion in regulated markets

Gaming Innovation Group Inc. (GiG) has applied for an online B2C casino and sports betting licence in Spain as part of its expansion in regulated markets. GiG will, as part of the licencing process, certify its B2B technical platform and offer its services and solutions to external licensed operators in the Spanish market. GiG will enter the Spanish market with both its B2C and B2B offering and is aiming to launch in H2 2019. Gambling is an important part of Spanish culture. The country has one of the highest per capita spending in Europe and has consistently grown during the past 20

Wallenstam introduces Kundo for improved accessibility and service

Wallenstam is now implementing Kundo, a web-based inquiry forum, which will provide tenants with quick answers through an intelligent and automatic search function. The content of the digital platform, which is now available on Wallenstam’s website, is being developed together with tenants based on the information, which is being requested.“We are now looking forward to be able to assist our customers with more service and improved accessibility. Through Kundo, we can offer our residents efficient answers around-the-clock. In addition, we can gather opinions and suggestions for improvement

Roxadustat approved in China for the treatment of anaemia in chronic kidney disease patients on dialysis

18 December 2018  09:00 GMT Roxadustat approved in China for the treatment ofanaemia in chronic kidney disease patients on dialysis China is the first country to approve roxadustat AstraZeneca today announced that its partner FibroGen (China) Medical Technology Development Co., Ltd. (FibroGen China) has now received formal marketing authorisation from the National Medical Products Administration (NMPA) for roxadustat, a first-in-class hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) and new oral treatment for patients with anaemia caused by chronic kidney disease (

New share-based long-term incentive scheme for the key personnel of Alma Media Corporation

Alma Media Corporation                               Stock Exchange Release                                December 18, 2018 at 11.15 a.m. NEW SHARE-BASED LONG-TERM INCENTIVE SCHEME FOR THE KEY PERSONNEL OF ALMA MEDIA CORPORATION The Board of Directors of Alma Media Corporation has decided on changes to the share-based long-term incentive scheme of the Company’s top management. The Board of Directors, at the same time, decided to establish a new share-based long-term incentive scheme for the other key personnel of Alma Media Corporation. The new plan structures commence effective from

Final result of Ahlstrom-Munksjö’s rights offering

AHLSTROM-MUNKSJÖ OYJ, STOCK EXCHANGE RELEASE December 18, 2018 at 11:15 a.m. This stock exchange release may not be published or distributed, in whole or in part, directly or indirectly, in or into Australia, Canada, Hong Kong, Japan, New Zealand, South Africa, Singapore or the United States or any other country where such publication or distribution would violate applicable laws or rules or would require additional documents to be completed or registered or require any measure to be undertaken, in addition to the requirements under Finnish law. For further information, see “Important

Statement by the Board of Directors of Cinnober Financial Technology in relation to the increased public offer from Nasdaq

The Board of Directors of Cinnober Financial Technology has concluded to unanimously recommend that the shareholders and warrant holders of Cinnober Financial Technology accept the increased public offer made by Nasdaq.Background This statement is made by the Board of Directors[1] (the “Board of Directors”) of Cinnober Financial Technology Aktiebolag (publ) (the “Company”, “Cinnober Financial Technology” or “Cinnober”) pursuant to Rule II.19 of the Swedish Corporate Governance Board’s takeover rules for certain trading platforms (the “Takeover Rules”). On September 14, 2018 Nasdaq

Valmet to supply a new baling line and cutter layboy upgrade to Sappi Saiccor pulp mill in South Africa

Valmet Oyj's trade press release on December 18, 2018 at 11:00 a.m. EET Valmet has received an order for a new baling line and a cutter layboy rebuild as part of the Vulindlela project at the Sappi Saiccor mill in South Africa. The start-up of the rebuilt cutter and the new baling line is scheduled for the third quarter of 2019. The order was included in Valmet's third quarter of 2018 orders received. An order with this scope of supply is usually valued around EUR 4 million. The overall targets for the Vulindlela project are to reduce the environmental footprint of the mill and to

UPM and United Bankers' forest funds have signed a contract on forest estate transaction and long-term partnership

(UPM, Helsinki, 18 December 2018 at 11:00 EET) - UPM and United Bankers have today signed a contract on forest estate transaction and long-term partnership. UPM sells over 21,000 hectares of land, located mainly in Kainuu region, to United Bankers forest funds UB Timberland and UB Nordic Forest Fund III. In the long-term partnership UPM commits to manage United Bankers forest property and United Bankers commits to sell a significant amount of wood to UPM annually. Target of the partnership is to increase the area and yield of forests owned by United Bankers subsidiary UB Fund Management

GJEB: Decision capital changes

Reference is made to the disclosure dated 18 December 2018 regarding proposed capital changes. The Board's proposals were adopted by the Extraordinary General Meeting 18 December 2018.Of the NOK 95,000,000 capital issue, NOK 94,124,000 will be allocated to premium reserve.Article 3 in the Articles of Association will be changed to: "The Company's share capital is NOK 979,368,000 divided into 876,000 shares, each with par value NOK 1,118. The shares shall be registered in a securities register." This information is subject to disclosure under Oslo Stock Exchange's ABM rules.

It’s In Your Hands – #IIYH: Sympatex social media campaign animates consumers to stand up for the environment

Under the motto “It’s In Your Hands,” consumers are being encouraged to become role models and do their part to protect the environment.Munich / Unterföhring, December 18, 2018 – On the heels of the launch of the radical awareness campaign during Outdoor 2018 in Friedrichshafen, Sympatex is now gearing up for a corresponding social media campaign. As a pioneer in sustainable functional textiles, Sympatex is targeting changes to processes in industry and society not only by raising awareness among its market partners in the fashion and outdoor industries, but also by directly addressing

Major order for GWS from Falck Global Assistance

GWS Production AB in Lund has received one of the company's largest and most important orders to date. The order means that Falck Global Assistance will use the security platform Safeture Pro from GWS, for several of its major customers. The initial total order value, spread between 1-3 years, is EUR 620 000.GWS is an international IT-company which works to help employees feel safe wherever they are. The company has developed Safeture, a security platform and a risk management tool for companies and business travelers. Safeture is the new way to guarantee employee safety using state-

EAB Group Plc: Elite Alfred Berg lowers its economic outlook 2018

EAB Group Plc, Company Announcement, 18 December 2018, 10:30 a.m. (EET) EAB Group Plc: Elite Alfred Berg lowers its economic outlook 2018 In connection with the half-year report on 24 August 2018, EAB Group Plc (the Company) estimated, according to the information available at the time of the report, that EAB Group's EBITDA (operating margin) would amount to approximately EUR 5 million in 2018. Due to the reasons specified below, the Company will remain from the estimation by around EUR 1-1.5 million and the operating margin in the financial year 2018 shall be around EUR 3.5 million.

Scandinavian Enviro Systems AB (publ) board and management subscribe for another 730,905 units in ongoing Rights Issue

Scandinavian Enviro Systems AB (publ) (”Enviro” or ”the Company”) announces today that the Board of Directors and Management will subscribe for an additional 730,905 units in the current rights issue with units of shares and warrants ("Rights Issue"), published on October 26, 2018. This press release refers to subscriptions in addition to the subscriptions of 2,185,415 units already entered into by the Board and Management.The terms of the Rights Issue include two (2) newly issued shares and two (2) warrants for each subscription and allotment unit. One (1) warrant entitles the holder to

GJEB: Proposed capital changes

The Board of Gjensidige Bank ASA has today 18 December 2018 decided to summon an Extraordinary General Meeting with a proposal to increase the share capital by NOK 95 million through a private placing towards the parent company Gjensidige Forsikring ASA.The increase of share capital is due to asset growth. This information is subject to disclosure under Oslo Stock Exchange's ABM rules. Contact person, Gjensidige Bank ASA:Head of Treasury: Tor Egil Nedrebø, Tel: +47 406 25 367Head of Investor Relations: Mitra Hagen Negård, Tel: +47 957 93 631

Biotage intends to initiate negotiations regarding an acquisition of Chreto ApS following a resolution not to exercise existing call option

Stockholm – Biotage AB (publ) (Biotage), (Nasdaq Stockholm: BIOT.ST) has today resolved to initiate negotiations to acquire the Danish company Chreto ApS (“Chreto”) following a decision not to exercise the current call option to acquire all outstanding shares in Chreto. On August 31, 2016, Biotage published that Biotage had invested 15 MDKK (corresponding to approx. 20.7 MSEK[1]) by subscription of new shares in Chreto. At the same time Biotage was granted an option that gave the right but not the obligation to acquire all outstanding shares in Chreto during the period up and until

Pilotfish delivers Vehicle IT for Dutch trains

The Swiss railway rolling stock manufacturer Stadler is delivering 69 trains to a public transport operator in the Netherlands. The Gothenburg-based company Pilotfish delivers one Vehicle Gateway communication unit for each train, through German IT specialist IVU Traffic Technologies AG, together with a number of core services like a cloud-based back-office system. - “We are happy for the opportunity to work with IVU and Stadler,” says Pilotfish CEO Tomas Gabinus.He continues, “Our solutions for busses and trams have great potential for trains, and the European ITxPT standard makes it

Vattenfall invests in new heat plant to help Uppsala reach its climate goals

Vattenfall has decided to invest in a new heating plant in Uppsala. As a result, the use of fossil fuels will cease and residents in Uppsala will be provided with fossil-free heating. The option of adding a turbine to boost electricity generation is also being investigated.Vattenfall has decided to invest a total of SEK 3.5 billion in generation facilities and grid infrastructure in Uppsala to streamline heat production and phase out fossil fuels. In accordance with the Uppsala Climate Protocol partnership, Vattenfall has undertaken to halve carbon dioxide emissions by 2020 and become fully

Caverion wins a building systems project for a sustainable office building in Germany

Caverion Corporation Investor news 18 December 2018 at 10:00 a.m. EETCaverion wins a building systems project for a sustainable office building in Germany Caverion and real estate developers Centrum Projektentwicklung GmbH in Düsseldorf and B + L Hamburg have signed a project agreement for the new office and retail building “KÖ-Bogen II” in Düsseldorf, Germany. Caverion will act as the technical general contractor and implement Air Conditioning, Cooling, and Heating & Sanitation. Caverion will also be responsible for the project execution plan. The value of the contract is approximately

Raisio plc: Announcement of Conveyance of Own Shares

Raisio plc      Stock Exchange Release, 18 December 2018 ANNOUNCEMENT OF CONVEYANCE OF OWN SHARES In March 2018, Raisio plc’s Annual General Meeting decided that of the monthly reward of the Chairman and members of the Board, approximately 20% shall be paid by distributing shares held by the company and approximately 80% in cash. Rewards shall be paid in two equal lots during the term in June and in December. Raisio plc has assigned a total of 7,110 free shares (RAIVV) on June 18, 2018 (other conveyance) as a reward to the Chairman and members of the Board for their managing duties.

Asarina Pharma Scientific Advisory Board gives full backing to Menstrual Migraine Phase IIA trial

Stockholm – December 18, 2018. On December 17 Asarina Pharma’s Scientific Advisory Board (SAB) gave its full backing to the company’s upcoming trial of a new preventive treatment for Menstrual Migraine. The SAB comprises world-leading independent scientists in obstetrics, gynaecology, neurology and pharmacology, including Prof Anne MacGregor, one of the world’s foremost authorities on headache and migraine.Migraine is more prevalent than diabetes, epilepsy and asthma combined, three times more women than men suffer from it, and 1-in-5 of those suffer from menstrual migraine. Yet currently

Cxense ASA closes divestment of Maxifier Ltd

Reference is made to the stock exchange announcement from Cxense ("Cxense" or the "Company) on 20 November 2018 regarding the divestment of Maxifier Ltd. The Company has today, 17 December 2018, finalized and closed the transaction for the sale of 70% of the shares in its wholly-owned subsidiary Maxifier Ltd to Bmax AS.   Investor Relations Contact:   Jørgen Evjen, Chief Financial Officer   Email: ir@cxense.com   Mobile: +47 928 04 014

There are no items matching the current filter
There are no more items matching the current filter
Back to top